Experimental and Therapeutic Medicine · 2017 · 11 citations · 23 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyRheumatologyAutoantibodiesAutoantibody-mediated DiseaseAutoantigensAutoimmune BiomarkersAutoimmune DiseasesSystemic SclerosisAutoantibodies In Rheumatic DiseaseAutoimmune SerologyBiomarkers Of Autoimmune ActivityClinical Laboratory EvaluationPathogenic AutoantibodiesRespiratory ConditionsSilicosisTissue Autoantibodies
Silicosis patients (SIL) suffer from respiratory disorders and dysregulation of autoimmunity. Frequent complications such as rheumatoid arthritis, systemic sclerosis (SSc) and vasculitis are known in SIL. Furthermore, we reported previously that some SIL exhibited better respiratory conditions in association with a worse immunological status. In this study, the clinical roles of anti-CENP-B and Scl-70 autoantibodies in SIL were analyzed. The titer index (Log10) of anti-CENP-B autoantibody in SIL was higher than that of healthy volunteers (HV), and that of SSc was higher than those of HV and SIL. This titer index was positively correlated with an assumed immune status of 1 for HV, 2 for SIL, and 3 for SSc. Moreover, although factor analysis revealed that the titer index of the anti-CENP-B autoantibody formed the same factor with the anti-Scl-70 autoantibody, IgG value and age in SIL cases, another extracted factor indicated that the IgA value and anti-Scl-70 antibody were positively related, but anti-CENP-B showed an opposite pattern in the results of the factor analysis. These findings indicated that the titer index of anti-CENP-B autoantibody may be a biomarker for dysregulation in SIL cases. Future clinical follow-up of SIL may therefore require both respiratory and immunological assessment.
23
Silica, silicosis and tuberculosis.
David Rees, Jill Murray · PubMed · 2007 · 214 citations
Immunological effects of silica and asbestos.
Takemi Otsuki, Megumi Maeda, Shuko Murakami et al. · PubMed · 2007 · 131 citations
Pharmacy, Immunology, Pathology +11
Silica, silicosis, and progressive systemic sclerosis.
G K Sluis-Cremer, P. A. Hessel, E H Nizdo et al. · Occupational and Environmental Medicine · 1985 · 125 citations · Full text
Pharmacy, Pathology, Toxicology +14